SPROUT PHARMACEUTICALS, INC. Patent applications |
Patent application number | Title | Published |
20160136161 | Use of Flibanserin in the Treatment of Obesity - The invention relates to compositions for the treatment of obesity and related diseases comprising a) an active substance being not flibanserin, selected from the group consisting of active substances for the treatment of obesity and obesity related diseases and b) flibanserin, optionally in the form of pharmacologically acceptable acid addition salts thereof. | 05-19-2016 |
20150126524 | Salts - The present invention relates to new crystalline salt forms of flibanserine which have valuable pharmacological properties, to a process for their manufacture, to pharmaceutical formulations containing them and to their use as medicament. | 05-07-2015 |
20150072994 | Use of Flibanserin in the Treatment of Obesity - The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin. | 03-12-2015 |
20150011564 | Sulfated Benzimidazolone Derivatives Having Mixed Serotonine Receptor Affinity - The present invention pertains to a compound of formula (I) | 01-08-2015 |
20140005203 | Treatment of Vasomotor Symptoms | 01-02-2014 |
20130209519 | FORMULATIONS OF FLIBANSERIN - The present invention provides pharmaceutical release systems comprising an therapeutically effective amount of flibanserin. | 08-15-2013 |
20130079355 | Use of Flibanserin in the Treatment of Obesity - The invention relates to a method for the treatment of obesity and related diseases comprising the administration of a therapeutically effective amount of Flibanserin. | 03-28-2013 |
20120270883 | USE OF A POLYMORPH OF FLIBANSERIN FOR TREATING DISEASE - The invention relates to the polymorph A of flibanserin, to a technical process for the preparation thereof, as well as to the use thereof for preparing medicaments. | 10-25-2012 |